Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mulligan

Showing results (421-430 of 529) with videos related to

Pageof 53
Sort By:
Ebiomedicine|November 20, 2023
Natural infection by Zika virus but not DNA vaccination consistently elicits antibodies that compete with two potently neutralising monoclonal antibodies targeting distinct epitopesTeresa C Smith, Daniel O Espinoza, Yerun Zhu, et al.
Vaccines|July 30, 2020
Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia VaccineYie-Hwa Chang, Duc M Duong, Johannes B Goll, et al.
Vaccines|July 8, 2020
Duration of Cellular and Humoral Responses after Quadrivalent Human Papillomavirus Vaccination in Healthy Female Adults with or without Prior Type 16 and/or 18 ExposureLilin Lai, Kevin Ault, Nadine Rouphael, et al.
Biorxiv : the Preprint Server for Biology|November 23, 2022
Inflammation durably imprints memory CD4+ T cellsSophie L Gray-Gaillard, Sabrina Solis, Han M Chen, et al.
The Journal of Infectious Diseases|July 12, 2012
Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older personsLisa A Jackson, Wilbur H Chen, Jack T Stapleton, et al.
Vaccines|December 28, 2019
Systems Vaccinology for a Live Attenuated Tularemia Vaccine Reveals Unique Transcriptional Signatures That Predict Humoral and Cellular Immune ResponsesMuktha S Natrajan, Nadine Rouphael, Lilin Lai, et al.
Vaccine|January 8, 2018
Antibody responses among adolescent females receiving two or three quadrivalent human papillomavirus vaccine doses at standard and prolonged intervalsLea E Widdice, Elizabeth R Unger, Gitika Panicker, et al.
Science Immunology|June 21, 2024
SARS-CoV-2 inflammation durably imprints memory CD4 T cellsSophie L Gray-Gaillard, Sabrina M Solis, Han M Chen, et al.
Vaccines|July 30, 2020
Transcriptomic and Metabolic Responses to a Live-Attenuated <i>Francisella tularensis</i> VaccineJohannes B Goll, Shuzhao Li, James L Edwards, et al.
Lancet (London, England)|July 2, 2017
The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trialNadine G Rouphael, Michele Paine, Regina Mosley, et al.
Pageof 53

Showing results (421-430 of 529) with videos related to

Sort By:
Pageof 53
Ebiomedicine|November 20, 2023
Natural infection by Zika virus but not DNA vaccination consistently elicits antibodies that compete with two potently neutralising monoclonal antibodies targeting distinct epitopesTeresa C Smith, Daniel O Espinoza, Yerun Zhu, et al.
Vaccines|July 30, 2020
Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia VaccineYie-Hwa Chang, Duc M Duong, Johannes B Goll, et al.
Vaccines|July 8, 2020
Duration of Cellular and Humoral Responses after Quadrivalent Human Papillomavirus Vaccination in Healthy Female Adults with or without Prior Type 16 and/or 18 ExposureLilin Lai, Kevin Ault, Nadine Rouphael, et al.
Biorxiv : the Preprint Server for Biology|November 23, 2022
Inflammation durably imprints memory CD4+ T cellsSophie L Gray-Gaillard, Sabrina Solis, Han M Chen, et al.
The Journal of Infectious Diseases|July 12, 2012
Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older personsLisa A Jackson, Wilbur H Chen, Jack T Stapleton, et al.
Vaccines|December 28, 2019
Systems Vaccinology for a Live Attenuated Tularemia Vaccine Reveals Unique Transcriptional Signatures That Predict Humoral and Cellular Immune ResponsesMuktha S Natrajan, Nadine Rouphael, Lilin Lai, et al.
Vaccine|January 8, 2018
Antibody responses among adolescent females receiving two or three quadrivalent human papillomavirus vaccine doses at standard and prolonged intervalsLea E Widdice, Elizabeth R Unger, Gitika Panicker, et al.
Science Immunology|June 21, 2024
SARS-CoV-2 inflammation durably imprints memory CD4 T cellsSophie L Gray-Gaillard, Sabrina M Solis, Han M Chen, et al.
Vaccines|July 30, 2020
Transcriptomic and Metabolic Responses to a Live-Attenuated <i>Francisella tularensis</i> VaccineJohannes B Goll, Shuzhao Li, James L Edwards, et al.
Lancet (London, England)|July 2, 2017
The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trialNadine G Rouphael, Michele Paine, Regina Mosley, et al.
Pageof 53